Moderna to Use New mRNA Technology to Develop Coronavirus Vaccine
Story Highlights In light of the coronavirus outbreak, three research teams have been awarded grants by the Coalition for Epidemic Preparedness Innovations to develop a vaccine for the novel coronavirus. In a public-private partnership with NIH, Moderna, Inc. is using an experimental mRNA technology to develop a vaccine. Johnson & Johnson and other drug companies […]
Coronavirus Vaccines on Fast Track as WHO Declares Global Public Health Emergency
A novel strain of a coronavirus (2019-nCoV) was first detected in the city of Wuhan, China on December 31, 2019 and, by the middle of January, thousands of Chinese citizens were sick. According to Johns Hopkins University Center for Science and Engineering, as of Jan. 30, 2020 there were 217 deaths among 9,776 confirmed coronavirus […]
Massachusetts Health Care Workers Refusing Free Flu Shots
Story Highlights Hundreds of health care workers in Massachusetts are declining the annual flu shot. Health care worker flu shot requirements vary from state to state. A recent study questions the scientific validity of mandating annual influenza vaccinations for hospital workers. Hundreds of health care workers in Massachusetts, including those in nursing homes and kidney […]
New Technology to Store Vaccination History in the Body
The Massachusetts Institute of Technology (MIT) News reported that researchers at the university have developed a way to record a person’s vaccination history and store the data in a pattern of dye, invisible to the naked eye, by infusing it under the skin at the same time the vaccine is given.1 The idea is to […]
Tamiflu on Track to Be an Over-The-Counter Drug
In July 2019, drug and French vaccine manufacturer Sanofi signed a deal with Roche Pharmaceuticals to obtain exclusive over-the-counter (OTC) rights for Tamiflu (oseltamivir), an antiviral drug licensed for the treatment of influenza infections. Genentech, a member of the Roche Group, currently sells Tamiflu in the United States only for prescription use.1 Tamiflu is a […]
Vaccine Market Valued at $93 Billion by 2026
A recent report by Fortune Business Insights projects the value of the world market for vaccines to reach $93.08 billion by 2026, with a Compound Annual Growth Rate (CAGR) of 10.7 percent during the forecast period.1 One of the main drivers of the vaccine market is the need for greater supplies of vaccines, given stricter government […]